CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the second quarter ended June 30, 2025, and recent business highlights. https://mma.prnewswire.com/media/1096384/CytoSorbents_Working_To_Save_Lives_Logo.jpg Second Quarter 2025 Financial Results — Revenue was $9.6 million, an increase of 9%, or […]

CPT Group, Inc., Named One of “Top 10 Trusted Legal Service Providers in 2025” by Insight Success Magazine

Recognition Highlights Four Decades of Excellence in Class Action Administration and Strategic Growth Through Leadership Evolution and Technology Innovation CPT Group, Inc., a leading class action settlement administrator with over 40 years of industry experience, has been recognized by Insight Success magazine as one of the “Top 10 Trusted Legal Service Providers in 2025.” This

Dynavax Reports Second Quarter 2025 Financial Results

— RecordHEPLISAV-B® quarterly net product revenue of $92 million, representing 31% year-over-year growth — Refines full year 2025HEPLISAV-B net product revenue guidance range to $315 to $325 million, from $305 to $325 million — Top-line results in Part 1 of Phase 1/2 shingles vaccine trial expected in August 2025 — Completed dosing in Part 1

Flint, Michigan or Alexandria, Indiana? The E. Coli Health Scandal You Were Never Meant to See

ALEXANDRIA, Ind., Aug. 07, 2025 (GLOBE NEWSWIRE) — A growing crisis is unfolding in Alexandria, Indiana, and it may be more dangerous than anyone is willing to admit. With alarming parallels to Flint, Michigan, where government denial led to irreversible harm, Alexandria now faces its own public health reckoning. “This time, we are not waiting

Questex’s FNTV in Partnership with Fierce Network Research to Release Groundbreaking Report: “Beyond Wi-Fi: 5G’s Rise to Wireless Dominance”

NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Questex's FNTV in partnership with Fierce Network Research is set to unveil the groundbreaking new report “Beyond Wi-Fi: 5G's Rise to Wireless Dominance.” The report showcases the dramatic reshaping of the future of global networks across enterprise, industry, and consumer markets. The comprehensive study explores the evolution

Pixalate’s July 2025 US Publisher Rankings: Top Mobile ‘Gaming’ Apps For Programmatic Advertising Traffic Quality in the Apple App Store and Google Play Store

London, Aug. 07, 2025 (GLOBE NEWSWIRE) — Pixalate, the leading ad fraud protection, privacy, and compliance analytics platform, today released the U.S. July 2025 Top Mobile Gaming Apps Rankings for Programmatic Advertising Traffic Quality on the Apple App Store and the Google Play Store. The report ranks mobile apps in the 'Video Gaming' IAB app

Total Return Securities Fund, Inc. Makes Announcement

(NYSE:SWZ), NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — The Board of Directors (the “Board”) of Total Return Securities Fund, Inc. (f/k/a The Swiss Helvetia Fund, Inc.) (the “Fund”) (NYSE: SWZ) today affirmed its previously announced intention to authorize a self-tender offer to purchase at least 15% of the Fund's outstanding shares at a price

Kratos Reports Second Quarter 2025 Financial Results

(NASDAQ:KTOS), Second Quarter 2025 Revenues of $351.5 Million Reflect 17.1 Percent Growth and 15.2 Percent Organic Growth Over Second Quarter 2024 Revenues of $300.1 Million Second Quarter 2025 Consolidated Book to Bill Ratio of 0.7 to 1 and Bookings of $257.0 Million Last Twelve Months Ended June 29, 2025 Consolidated Book to Bill Ratio of

GigaCloud Technology Inc Announces Second Quarter and Six Months Ended June 30, 2025 Financial Results

(NasdaqGM:GCT), EL MONTE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced financial results for the second quarter and six months ended June 30, 2025. Second Quarter 2025 Financial Highlights Total revenues of $322.6

Cognition Therapeutics Reports Financial Results for the Second Quarter 2025 and Highlights Progress Across Clinical Programs

(NASDAQ:CGTX), – Discussed plans to support a pivotal Alzheimer's disease program with FDA at end-of-phase 2 meeting – – Initiated expanded access program (EAP) for people with dementia with Lewy bodies (DLB) – – Surpassed 50% enrollment in Phase 2 'START' study of zervimesine in early Alzheimer's disease – PURCHASE, N.Y., Aug. 07, 2025 (GLOBE

Scroll to Top